SEC Comment Letter for ALNYLAM PHARMACEUTICALS, INC. (ALNY) (CIK 0001178670) (ALNY) — Mar 23, 2011
ALNYLAM PHARMACEUTICALS, INC. (ALNY) (CIK 0001178670)
Date: March 23, 2011 · CIK: 0001178670 · Accession: 0000000000-11-017833
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-50743
Letter
Re: Alnylam Pharmaceuticals, Inc. Form 10-K Filed February 26, 2010 File No. 000-50743 Dear Mr. Maraganore: We have completed our review of your fili ng and do not have any further comments at this time. Sincerely, Jeffrey Riedler Assistant Director
March 23, 2011
John M. Maraganore, Ph.D. Chief Executive Officer Alnylam Pharmaceuticals, Inc. 300 Third Street Cambridge, MA 02142
Show Raw Text
March 23, 2011
John M. Maraganore, Ph.D. Chief Executive Officer Alnylam Pharmaceuticals, Inc. 300 Third Street
Cambridge, MA 02142
Re: Alnylam Pharmaceuticals, Inc. Form 10-K
Filed February 26, 2010 File No. 000-50743
Dear Mr. Maraganore:
We have completed our review of your fili ng and do not have any further comments at
this time.
Sincerely,
Jeffrey Riedler
Assistant Director